<p class="bodytext">Jim Momtazee, a former dealmaker at US buyout firm KKR & Co Inc, has launched his own firm to pursue private equity deals in the healthcare sector.</p>.<p class="bodytext">Momtazee, who spent 21 years at KKR and led its Americas healthcare team for a decade, said in a statement he formed Patient Square Capital together with Maria Walker, a former partner at consulting firm KPMG.</p>.<p class="bodytext">The move comes as the outbreak of the novel coronavirus has strained some healthcare providers, while spurring growth in some sectors such as telemedicine and vaccine production.</p>.<p class="bodytext">Patient Square Capital plans to look for deals across the healthcare industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health, the statement said.</p>.<p class="bodytext">"We're going to be broad-based in our focus on all aspects of healthcare, bringing depth of knowledge, scale, expertise, and long-term view to our investments," Momtazee told Reuters in an interview.</p>.<p class="bodytext">Prior to leaving KKR last year, Momtazee worked on some of the buyout firm's biggest healthcare deals, including the $33 billion take-private of US hospital operator HCA Healthcare Inc, as well as the acquisition of contract research firm PRA International for $1.3 billion in 2013.</p>
<p class="bodytext">Jim Momtazee, a former dealmaker at US buyout firm KKR & Co Inc, has launched his own firm to pursue private equity deals in the healthcare sector.</p>.<p class="bodytext">Momtazee, who spent 21 years at KKR and led its Americas healthcare team for a decade, said in a statement he formed Patient Square Capital together with Maria Walker, a former partner at consulting firm KPMG.</p>.<p class="bodytext">The move comes as the outbreak of the novel coronavirus has strained some healthcare providers, while spurring growth in some sectors such as telemedicine and vaccine production.</p>.<p class="bodytext">Patient Square Capital plans to look for deals across the healthcare industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health, the statement said.</p>.<p class="bodytext">"We're going to be broad-based in our focus on all aspects of healthcare, bringing depth of knowledge, scale, expertise, and long-term view to our investments," Momtazee told Reuters in an interview.</p>.<p class="bodytext">Prior to leaving KKR last year, Momtazee worked on some of the buyout firm's biggest healthcare deals, including the $33 billion take-private of US hospital operator HCA Healthcare Inc, as well as the acquisition of contract research firm PRA International for $1.3 billion in 2013.</p>